New Treatment for Donor Sites
Summary
Primary research questions/Purpose of the Research. 1. Determine the short term (epidermal regeneration, reduction of pain, infections and length of stay) and long term (scarring, long term recovery, and cost of treatment) outcomes of Microbial Nanocellulose (NC) and fine mesh gauze impregnated with hyaluronan and thrombin (HT). 2. Determine if donor site treatment with NC and HT is as safe as the use of Scarlet Red ointment dressing. b. Describe the importance of the knowledge that you expect to gain from the research. To find a donor site dressing that has outcomes equal or better than that of scarlet red.
Timeline
- Start
- 2006-01
- Primary completion
- 2010-11
- Completion
- 2010-11
Outcome
Outcome not reported
Stopped: “Donor site material (scarlet red ) came back on the market, therefore new treatements for donor sites was not needed.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyaluronan | Other / unclassified | — | — |
| Subject | Scarlet Red | Small molecule | — | — |
| Subject | thrombin | Protein / enzyme biologic | — | — |
Indications
No indication recorded.